The Laboratory of Viral Diseases hosted a two-day enterovirus molecular characterization workshop on July 28th and 29th. The training was sponsored by the Association of Public Health Laboratories (APHL) and included scientists from state public health laboratories in New Jersey, Oregon, Michigan, Washington, California, Massachusetts, and Nebraska.  

Dr. Joseph Orsini, Director of the Newborn Screening Program’s Biochemical Genetics Laboratory, represented the Wadsworth Center at the Hunter’s Hope Medical Symposium, held July 15-16, 2025, in Ellicottville, NY. He has attended this annual symposium since 2008, which brings together scientists, clinicians, newborn screening professionals, and families to advance understanding of Krabbe Disease and other leukodystrophies. 

The Wadsworth Center, the public health laboratory of the New York State Department of Health, has been selected to serve as the central reference testing laboratory for a major international clinical trial aimed at preventing multidrug-resistant tuberculosis (MDR-TB) in vulnerable populations.

Dr. Spencer Bruce, Director of the Bioinformatics Core at the Wadsworth Center, recently took part in the Bioinformatics Leadership Program, held June 23-27, 2025, at the Association of Public Health Laboratories (APHL) headquarters in Bethesda, Maryland.  

The University of Miami Miller School of Medicine Division of Infectious Diseases, with support from the Mycoses Study Group Education and Research Consortium and the Centers for Disease Control and Prevention, hosted a 2025 Scientific Meeting on Candida auris in Miami, Florida from June 5-6, 2025.  

The Wadsworth Center’s Newborn Screening Program published their 2024 annual report, which provides an overview of screening results for each of the mandated conditions on the New York State panel. The 2024 panel included more than 50 conditions. In 2024, 246,895 specimens from 206,728 infants were screened, corresponding to an average of nearly 1,000 specimens for 50 conditions each day (50,000 screens performed daily). A total of 1,866 infants screened positive for one of the conditions on the panel and were referred for diagnostic testing, evaluation, follow-up and treatment.

Wadsworth Center received the 2025 APHL Award for Excellence in Applied Research on Infectious Diseases, recognizing outstanding contributions to the field of infectious disease laboratory research, with a particular focus on public health laboratory impact. The award acknowledges the important work of public health laboratorians that bridges scientific discovery and innovation with practical application.

Drs. Rajendra Agrawal and Soneya Majumdar represented the Wadsworth Center at Ribosomes 2025, the Triennial Ribosome Meeting held June 22–27 in Asilomar, Pacific Grove, California.  

On June 25–26, the Newborn Screening Mass Spectrometry Laboratories at the Wadsworth Center hosted Dr. Naija Cottingham, a Fellow from the Icahn School of Medicine at Mount Sinai.  Dr. Cottingham is the first participant in this new Fellowship Program, initiated by Dr. Jaya Ganesh, Interim Program Director of the Medical Residency Training Program and Director of the Newborn Screening Inherited Metabolic Disease Specialty Care Center at Mount Sinai.  

On June 25, 2025, Dr. Sherry Faye, Technical Director of the Wadsworth Center’s Nuclear Chemistry Laboratory (NCL), served as an invited guest speaker at the U.S. Department of Energy and American Chemical Society-sponsored Nuclear Chemistry Summer School (NCSS) at Brookhaven National Laboratory.  This highly selective six-week program is designed to introduce undergraduate students to careers in nuclear science.  Dr. Faye presented an overview of the NCL’s mission and capabilities, including: